Papers

3

Total Citations

44

H-Index

3

About

Michel Mittelbronn is a leading neuropathologist whose research bridges cutting-edge optical spectroscopy and clinical neuro-oncology. His primary focus lies in developing label-free, real-time diagnostic tools for brain tumor surgery, most notably using Raman spectroscopy to intraoperatively discriminate meningioma from normal dura mater—a critical step for achieving total resection and reducing tumor recurrence. His 2021 study on this technique has garnered 26 citations, underscoring its translational promise. Beyond spectroscopy, Mittelbronn has made significant contributions to pediatric neuro-oncology, demonstrating that biopsies of brainstem lesions, though technically challenging, carry low morbidity and profoundly influence treatment decisions (15 citations). He is also advancing tumor banking methodologies, investigating how cryofixation and formalin fixation affect Raman spectra to enable robust classifier training from biobanked samples. His work is characterized by a rare synergy between molecular pathology and biomedical optics, positioning him as a key figure in the push toward precision neurosurgery. Mittelbronn’s research not only improves surgical outcomes but also lays the groundwork for integrating spectroscopic analysis into routine pathological workflows.

Research Focus

Key Achievements

3
H-Index
3
Papers
44
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Intraoperative discrimination of native meningioma and dura mater by Raman spectroscopy
26 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Luxembourg Institute of Health, Goethe University Frankfurt, Centre Hospitalier de Luxembourg

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago